Genotype
|
Weeks
|
Treatment
|
TSS2
|
TSS3
|
---|
| | |
Average
|
SD
|
t-test (p)
|
Average
|
SD
|
t-test (p)
|
---|
| | |
(Fold difference)
| | |
(Fold difference)
| | |
---|
9621-67
|
1
|
Control
|
0.66
|
0.36
| |
0.62
|
0.19
| |
| |
Xf-Infected
|
17.65**
|
4.83
|
0.001854
|
0.50
|
0.15
|
0.204438
|
|
6
|
Control
|
9.20
|
4.26
| |
0.35
|
0.11
| |
| |
Xf -Infected
|
37.12*
|
14.68
|
0.017017
|
8.67**
|
1.66
|
0.000483
|
9621-94
|
1
|
Control
|
1.00
|
0.00
| |
1.00
|
0.00
| |
| |
Xf -Infected
|
2.22**
|
0.42
|
0.003532
|
0.40**
|
0.10
|
0.000203
|
|
6
|
Control
|
1.56
|
0.43
| |
0.60
|
0.20
| |
| |
Xf -Infected
|
1.42
|
0.41
|
0.354589
|
0.23*
|
0.02
|
0.017818
|
- ** Significant level at P < 0.01; * Significant level at P < 0.05.